|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/20 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3351261 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18160057.8 |
| Europos patento paraiškos padavimo data | 2012-10-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 11184644 | 2011-10-11 | EP | |
| 11188625 | 2011-11-10 | EP | |
| 12185108 | 2012-09-19 | EP |
| (72) |
BECHER, Burkhard , CH
VOM BERG, Johannes , CH
|
| (73) |
Universität Zürich ,
Rämistrasse 71, 8006 Zürich,
CH
|
| (54) | COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY |
| COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY |